| Identification | Back Directory | [Name]
KRAS G12C inhibitor 16 | [CAS]
2349392-79-4 | [Synonyms]
KRAS G12C inhibitor 16
KRAS G-12C inhibitor 16,KRAS G12C inhibitor 16
2-Propen-1-one, 1-[(4aR)-11-chloro-10-(2-fluoro-6-hydroxyphenyl)-1,2,4a,5-tetrahydro-9-methylpyrazino[1',2':4,5][1,4]oxazino[2,3-c]quinolin-3(4H)-yl]- | [Molecular Formula]
C24H21ClFN3O3 | [MDL Number]
MFCD32201077 | [MOL File]
2349392-79-4.mol | [Molecular Weight]
453.89 |
| Hazard Information | Back Directory | [Uses]
KRAS G12C inhibitor 16 is a potent KRAS G12C inhibitor extracted from patent WO2019110751A1, compound 39, has an IC50 of 97 nM[1]. | [IC 50]
KRas G12C: 97 nM (IC50) | [References]
[1] Jason Grant Kettle, et al. Tetracyclic compounds as inhibitors of g12c mutant ras protein, for use as anti-cancer agents. WO2019110751A1. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|